ROIV
Roivant Sciences Ltd
35.80$
+0.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5,384.5% | -1,352.3% | -374.9% | -5,962.1% | -5,962.1% | -2,298.2% | -2,279.6% | -9,418.6% | -11,818.2% | -9,829.1% | -6,500.7% | -18,266.0% | -10,745.6% | |
| 199.6% | 34.6% | 7.1% | 108.2% | 108.2% | 32.4% | 18.8% | 50.6% | 58.6% | -401.8% | 1,200.2% | 41.6% | 315.1% | |
| 1,351.9% | 349.1% | 161.5% | 1,601.5% | 1,601.5% | 927.9% | 1,102.9% | 3,787.0% | 5,208.2% | 5,252.5% | 3,062.3% | 5,779.6% | 4,611.4% | |
| 2,476.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 469.5% | 136.2% | 55.2% | 230.4% | 230.4% | -588.9% | 455.5% | -1,712.7% | 450.4% | 468.8% | -23,852.3% | 493.0% | -7,667.6% | |
| 7.5% | 2.3% | 1.2% | 22.3% | 22.3% | 20.3% | 10.7% | 185.9% | 499.6% | 246.9% | 50.0% | 29.1% | 192.0% | |
| -999.2% | 33,627.0% | 23.9% | -73,599.9% | -73,599.9% | 5,035.2% | 14,190.1% | -50,033.0% | 7,665.3% | 7,439.7% | 5,327.0% | 19,504.9% | 9,089.8% | |
| 164.5% | – | 20.7% | – | – | – | – | – | – | – | – | – | – | |
| -5,908.1% | 0.0% | 768.1% | -2,369.9% | -2,369.9% | -2,698.5% | -3,902.8% | -9,598.8% | 0.0% | 0.0% | -4,413.1% | -14,336.3% | -4,221.2% | |
| -207.5% | – | – | – | -41.0% | -544.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | |
| 5,698.2% | 1,520.6% | -112.8% | -2,437.4% | -2,437.4% | -3,026.7% | -2,340.2% | -8,652.9% | 3,983.9% | 14,454.4% | -1,171.7% | -26,923.6% | -879.4% | |
| -703.2% | 33,814.9% | -615.1% | -81,886.7% | -81,886.7% | -301.6% | 9,563.9% | -68,066.9% | -92.2% | 12,086.5% | -2,293.2% | -25,662.9% | -2,491.8% | |
| -5,392.1% | -1,354.6% | -376.1% | -5,984.4% | -5,984.4% | -2,318.5% | -2,290.3% | -9,604.5% | -12,317.8% | -9,582.2% | -6,550.8% | -18,295.0% | -10,806.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.